Comparison between combined oral and topical 5-ASA versus topical 5-ASA on ulcerative proctitis.
Phase 2
Recruiting
- Conditions
- lcerative proctitis.Ulcerative (chronic) proctitisK51.2
- Registration Number
- IRCT20231029059892N1
- Lead Sponsor
- Arak University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 64
Inclusion Criteria
All people who have been diagnosed with ulcerative proctitis through colonoscopy and histology during the years 1398-1402.
Patients over 15 years old
Exclusion Criteria
Patients with salicylate allergy
Active peptic disease
A proven coagulation problem
Pregnant and lactating women
Significant liver and kidney disease
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Severity of disease activity. Timepoint: Start of study and 3 and 6 months later. Method of measurement: Simple Clinical Colitis Activity Index (SCCAI) And Disease Activity Index (DAI).;Response to treatment. Timepoint: Start of study and 6 months later. Method of measurement: Colonoscopy and Biopsy.;Laboratory criteria. Timepoint: Start of study and 3 and 6 months later. Method of measurement: Blood test.
- Secondary Outcome Measures
Name Time Method